1st Quarter - Amendment

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
$1,340,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 19, 2018 $1,340,000 Replaced
1st Quarter - Amendment (this page) Jan 21, 2019 $1,340,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax reform

LobbyistCovered position, as disclosed
JESSE PRICE —
JENNIFER ROMANS —
SONYA SOTAK ELLING —
ERIC J. STEINER —

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Homeland Security, Dept of (DHS); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

Intellectual property

LobbyistCovered position, as disclosed
JESSE PRICE —

Contacted: Commerce, Dept of (DOC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); State, Dept of (DOS)

Health Issues HCR

Patient protection; Drug shortages; Drug pricing and value; Dormant Therapies Act; PDUFA; BSUFA

LobbyistCovered position, as disclosed
JOE KELLEY —
JENNIFER ROMANS —
SONYA SOTAK ELLING —
DAVID TALBOT —

Contacted: Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Natl Institutes of Health (NIH); State, Dept of (DOS); Commerce, Dept of (DOC); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession

LobbyistCovered position, as disclosed
ANJULEN ANDERSON REILLY —
HARRISON C COOK —
CATHERINE HINCKLEY —
JESSE PRICE —
JESSE SEVCIK —
ERIC J. STEINER —
DAVID TALBOT —

Contacted: State, Dept of (DOS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Intellectual property; Dormant Therapies Act; 340B Program; Medicare Part B and Part D; PPACA; IPAB repeal

LobbyistCovered position, as disclosed
JESSE PRICE —
JENNIFER ROMANS —
SONYA SOTAK ELLING —

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Justice, Dept of (DOJ); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Agriculture, Dept of (USDA); Commerce, Dept of (DOC)

Consumer Issues/Safety/Products CSP

Anti-counterfeiting; Patient safety; Drug pedigree; Serialization and traceability issues; Drug Quality and Security Act; Protecting consumers from illegal online drug sales; Promoting public-private partnerships; UN High Level Panel on Access to Medicines (UNHLP) and other multi-lateral threats to IP and the biopharmaceutical industry; Drug importation

LobbyistCovered position, as disclosed
JESSE PRICE —
JENNIFER ROMANS —

Contacted: Office of Management & Budget (OMB); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA)

Animals ANI

Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation

LobbyistCovered position, as disclosed
ANJULEN ANDERSON REILLY —
JESSE SEVCIK —
ERIC J. STEINER —

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); Office of Management & Budget (OMB)

Pharmacy PHA

Hospital discounts; 340B program

LobbyistCovered position, as disclosed
JENNIFER ROMANS —
SONYA SOTAK ELLING —

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Homeland Security, Dept of (DHS); State, Dept of (DOS); Justice, Dept of (DOJ); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.